Illustration showing how cationic nanomaterials target depot-specific fat cells.
Credit: Qianfen Wan/CUIMC and Baoding Huang/Columbia Engineering
Columbia researchers discover that the cationic charged P-G3 reduces fat at targeted locations by inhibiting the unhealthy lipid storage of enlarged fat cells
Researchers have long been working on how to treat obesity, a serious condition that can lead to hypertension, diabetes, chronic inflammation, and cardiovascular diseases. Studies have also revealed a strong correlation of obesity and cancer–recent data show that smoking, drinking alcohol, and obesity are the biggest contributors to cancer worldwide.The development of fat cells, which are produced from a tiny fibroblast-like progenitor, not only activates the fat cells’ specific genes but also grows them by storing more lipids (adipocytes and adipose tissue). In fact, lipid storage is the defining function of a fat cell. But the storage of too much lipid can make fat cells unhealthy and lead to obesity.
Challenges in targeting fat cells
The ability to target fat cells and safely uncouple unhealthy fat formation from healthy fat metabolism would be the answer to many peoples’ prayers. A major challenge in obesity treatment is that fat tissue, which is not continuous in the body but is found piece by piece in “depots,” has been difficult to target in a depot-specific manner, pinpointed at the exact location.
There are two main kinds of fat: visceral fat, internal tissues that surround the stomach, liver, and intestines, and subcutaneous fat, found under the skin anywhere in the body. Visceral fat produces potbellies; subcutaneous fat can create chin jowls, arm fat, etc. To date, there has been no way to specifically treat visceral adipose tissue. And current treatments for subcutaneous fat like liposuction are invasive and destructive.
New studies use cationic nanonmaterials to target fat
Two new studies from researchers at Columbia Engineering and Columbia University Irving Medical Center (CUIMC) may have the answer to targeting fat cells depot-specifically and healthily. The papers demonstrate a new method to treat obesity by using cationic nanomaterials that can target specific areas of fat and inhibit the unhealthy storage of enlarged fat cells. The materials remodel fat rather than destroying it, as, for example, liposuction does.
The first paper, published today by Nature Nanotechnology, focuses on visceral adiposity, or belly fat. The second paper, published online November 28 by Biomaterials, focuses on fat underneath the skin as well as chronic inflammation associated with obesity.
The team of researchers, led by Li Qiang, associate professor of pathology and cell biology at CUIMC, and Kam Leong, Samuel Y. Sheng Professor of Biomedical Engineering and of systems biology at CUIMC, recognized that adipose tissue contains large amounts of negatively charged extracellular matrix (ECM) to hold fat cells. They thought that this negatively charged ECM network might provide a highway system of sorts for positively charged molecules. So they took a positively charged nanomaterial, PAMAM generation 3 (P-G3), and injected it into obese mice. The P-G3 quickly spread throughout the tissue and the team was excited that their method to specifically target visceral fat worked.
Unexpected results
And then something intriguing happened: P-G3 shut off the lipid storage program in fat cells and the mice lost weight. This was totally unexpected, given the well-established function of P-G3 in neutralizing negatively charged pathogens, such as DNA/RNA cell debris, to alleviate inflammation.“Our approach is unique–It departs from the pharmacological or surgical approaches,” says Qiang, who specializes in obesity and adipocyte biology. “We used cationic charge to rejuvenate healthy fat cells, a technique no one has ever used to treat obesity. I think this novel strategy will open the door to healthier and safer reduction of fat.”
P-G3 helps new fat cell formation and also inhibits the unhealthy lipid storage of enlarged fat cells
With P-G3, fat cells can still be fat cells, but they can’t grow up. Our studies highlight an unexpected strategy to treat visceral adiposity and suggest a new direction of exploring cationic nanomaterials for treating metabolic diseases.
KAM LEONG – SAMUEL Y. SHENG PROFESSOR OF BIOMEDICAL ENGINEERING AND OF SYSTEMS BIOLOGY AT CUIMC
In these two studies, the researchers discovered that the cationic material, P-G3, could do an intriguing thing to fat cells–while it helped new fat cell formation, it also uncoupled lipid storage from the housekeeping functions of fat cells. And because it inhibits the unhealthy lipid storage of enlarged fat cells, the mice had more metabolically healthy, young, small fat cells like those found in newborns and athletes. The researchers found that this uncoupling function of P-G3 also holds true in human fat biopsies, signifying the potential of translation in humans.“With P-G3, fat cells can still be fat cells, but they can’t grow up,” said Leong, a pioneer in using polycation to scavenge pathogens. “Our studies highlight an unexpected strategy to treat visceral adiposity and suggest a new direction of exploring cationic nanomaterials for treating metabolic diseases.”
New applications for drug delivery, gene therapy, and aesthetics
Now that they can selectively target visceral fat, Leong and Qiang envision several applications. The Biomaterials study demonstrates a simple approach that could be used for aesthetic purposes; like Botox, P-G3 can be locally injected into a specific, subcutaneous fat depot. The investigators, who have patents pending, are now engineering P-G3 into various derivatives to improve the efficacy, safety, and depot specificity.
What the researchers are particularly excited about is developing P-G3 into a platform that can deliver drugs and gene therapies specifically to a given fat depot. This may repurpose many drugs from systemic safety concerns, such as Thiazolidinediones (TZDs), a potent but unsafe drug that is a strong modulator of fat and used to treat type 2 diabetes—but it has been linked to heart failure and banned in several countries.
“We’re very excited to discover that cationic charge is the secret to targeting adipose tissue,” Qiang said. “Now we can shrink fat in a depot-specific manner–anywhere we want–and in a safe way without destroying fat cells. This is a major advance in treating obesity.”
Original Article: Positively Charged Nanomaterials Treat Obesity Anywhere You Want
More from: Fu Foundation School of Engineering and Applied Science | Columbia University Irving Medical Center
The Latest Updates from Bing News
Go deeper with Bing News on:
Treating obesity
- FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight
The U.S. Food and Drug Administration recently approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults with ...
- Billie Jean King, 80, opens up about trying Ozempic to treat binge eating disorder:
As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.
- Understanding the cellular mechanisms of obesity-induced inflammation and metabolic dysfunction
A South Korean team has spearheaded a research endeavor that successfully uncovered the mechanisms governing inflammation and metabolic dysfunction in tissues associated with obesity. Their findings ...
- Study identifies driver of liver cancer that could be target for treatment
Inhibiting a certain protein in mice reduced obesity-induced liver tumor development, Yale researchers found. It could reveal a future treatment route.
- Dr Diana Isaacs Surveys Emerging Diabetes, Obesity, and Cardiometabolic Treatment Landscape
Diana Isaacs, PharmD, chair of a recent Institute for Value-Based Medicine® event hosted in conjunction with Cleveland Clinic, details the up-and-coming therapies impacting the scope of treatment in ...
Go deeper with Bing News on:
Obesity
- Lexi had surgery for obesity at 12. Now she could be facing a lifetime on weight-loss drugs
One in five children and adolescents in the United States are affected by obesity. And parents are turning to radical treatments like surgery and weight-loss drugs.
- Reyna: How IDEA Mission is taking action against rising obesity rates
Recognizing the urgency, the IDEA Mission HOSA Obesity Awareness Campaign has taken proactive measures to address this critical health issue head-on.
- Why the obesity drug market is about to get a lot more crowded
The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.
- Managing Obesity Can Lead to Sarcopenia: A 'Hidden' Problem
ASUNCIÓN, PARAGUAY — Sarcopenic obesity, which is characterized by excess adiposity and muscle loss, is an "underestimated and underdiagnosed" condition, said the panelists at a session of the XV ...
- Advocates urge Austin to act on active duty obesity ‘epidemic’
In a 2022 report, the Centers for Disease Control and Prevention found that 19% of active duty service members were obese, up from 16% in 2015. The report said DOD spends about $1.5 billion a year in ...